Package Leaflet: Information for the User
Olanzapine NORMON 10 mg orodispersible tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Olanzapine NORMON contains the active substance olanzapine. Olanzapine NORMON belongs to a group of medicines called antipsychotics and is used to treat the following diseases:
Olanzapine NORMON has been shown to prevent the recurrence of these symptoms in patients with bipolar disorder whose manic episodes have responded to treatment with olanzapine.
Do not take Olanzapine NORMON
Warnings and precautions
Consult your doctor or pharmacist before starting to take Olanzapine NORMON
If you suffer from any of the following diseases, inform your doctor as soon as possible:
If you suffer from dementia, you or your caregiver or family member should inform your doctor if you have ever had a stroke or a lack of blood flow to the brain.
As a routine precaution, if you are over 65 years old, it would be advisable for your doctor to check your blood pressure.
Children and adolescents
Patients under 18 years of age should not take Olanzapine NORMON.
Other medicines and Olanzapine NORMON
Only use other medicines at the same time as Olanzapine NORMON if your doctor authorizes it. You may feel a certain sensation of sleepiness if you combine Olanzapine NORMON with antidepressants or medications for anxiety or that help you sleep (tranquilizers).
Tell your doctor if you are taking, have recently taken, or may need to take any other medication.
In particular, tell your doctor if you are taking:
Use of Olanzapine NORMON with alcohol
Do not drink alcohol while taking Olanzapine NORMON, as the combination with alcohol can cause sleepiness.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. You should not take this medicine while breastfeeding, as small amounts of Olanzapine NORMON may pass into breast milk.
The following symptoms may occur in newborn babies of mothers who have been treated with Olanzapine NORMON in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness and/or muscle weakness, sleepiness, agitation, breathing problems, and difficulty feeding.
If your baby develops any of these symptoms, contact your doctor.
Driving and using machines
There is a risk of sleepiness when taking Olanzapine NORMON. If this happens to you, do not drive vehicles or use machinery. Consult your doctor.
Olanzapine NORMON contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Follow exactly the administration instructions of this medicine indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Your doctor will indicate how many Olanzapine NORMON orodispersible tablets you should take and for how long. The daily dose of Olanzapine NORMON ranges from 5 mg to 20 mg. Consult your doctor if you suffer from symptoms again, but do not stop taking Olanzapine NORMON unless your doctor tells you to.
The Olanzapine NORMON orodispersible tablets should be taken once a day, following your doctor's instructions. Try to take the tablets at the same time every day. You can take them with or without food. The Olanzapine NORMON orodispersible tablets are for oral administration.
The Olanzapine NORMON orodispersible tablets dissolve easily, so they should be handled with care. Do not handle the tablets with wet hands, as they may dissolve.
1 & 2. Hold the blister pack by the ends
You can also put the tablet in a cup or glass filled with water, orange juice, apple juice, milk, or coffee, stirring it. With some beverages, the mixture may change color and appear cloudy. It should be drunk immediately.
If you take more Olanzapine NORMON than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested. Show the doctor the package with the tablets.
Patients who have taken more Olanzapine NORMON than they should have experienced the following symptoms: rapid heartbeat, agitation/aggression, speech problems, unusual movements (especially of the face and tongue), and a reduced level of consciousness. Other symptoms may include: acute confusion, seizures (epilepsy), coma, a combination of fever, rapid breathing, sweating, muscle stiffness, and a state of confusion or drowsiness, slowing of respiratory rate, aspiration, increased or decreased blood pressure, and abnormal heart rhythms. Contact your doctor or go to the hospital immediately if you experience any of the above symptoms. Show the doctor the package with the tablets.
If you forget to take Olanzapine NORMON
Take your tablet as soon as you remember. Do not take a double dose to make up for forgotten doses.
If you stop taking Olanzapine NORMON
Do not stop treatment just because you feel better. It is very important that you continue taking Olanzapine NORMON while your doctor tells you to.
If you stop taking Olanzapine NORMON suddenly, symptoms such as sweating, insomnia, tremors, anxiety, or nausea and vomiting may appear. Your doctor may suggest that you gradually reduce the dose before stopping treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor immediately if you have:
Very common side effects (which can affect more than 1 in 10 people) include weight gain; sleepiness; and increased prolactin levels in the blood. In the early stages of treatment, some people may feel dizzy or faint (with slower heartbeats), especially when getting up from a lying or sitting position. This feeling usually disappears on its own, but if it does not, consult your doctor.
Common side effects (which can affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating lipids, and temporary increases in liver enzymes at the start of treatment; increased blood sugar and urine levels; increased uric acid and creatine phosphokinase levels in the blood; increased appetite; dizziness; agitation; tremors; unusual movements (dyskinesia); constipation; dry mouth; skin rash; loss of strength; excessive fatigue; fluid retention that causes swelling of the hands, ankles, or feet; fever, joint pain, and sexual dysfunctions such as decreased libido in men and women or erectile dysfunction in men.
Rare side effects (which can affect up to 1 in 100 people) include hypersensitivity (e.g., inflammation of the mouth and throat, itching, skin rash); diabetes or worsening of diabetes, occasionally related to ketoacidosis (acetone in blood and urine) or coma; seizures, in most cases related to a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; speech problems; stuttering; slow pulse; sensitivity to sunlight; nosebleeds; abdominal distension; excessive salivation; memory loss or forgetfulness; urinary incontinence; loss of urination ability; hair loss; absence or decrease of menstrual periods; and changes in the mammary gland in men and women, such as abnormal milk production or abnormal growth.
Very rare side effects (which can affect up to 1 in 1000 people) include a drop in normal body temperature; abnormal heart rhythm; sudden unexplained death; pancreatitis, which causes severe stomach pain, fever, and discomfort; liver disease, with yellowing of the skin and the white areas of the eyes; muscle disorder that presents as unexplained pain and prolonged and/or painful erections.
Very rare side effects include severe allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Initially, DRESS manifests with flu-like symptoms with rashes on the face and later with extensive rash, fever, swollen lymph nodes, elevated liver enzymes observed in blood tests, and an increase in a type of white blood cell in the blood (eosinophilia).
During treatment with olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary incontinence, falls, extreme fatigue, visual hallucinations, a rise in body temperature, skin redness, and walking problems. Some deaths have been reported in this particular group of patients.
Olanzapine NORMON may worsen symptoms in patients with Parkinson's disease.
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the package after CAD. The expiration date is the last day of the month indicated.
Olanzapine NORMON should be stored in its original packaging to protect it from light and moisture.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point of your pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Olanzapine NORMON
Appearance of the product and contents of the pack
The Olanzapine NORMON 10 mg orodispersible tablets are yellow.
Orodispersible tablet is the technical name for a tablet that dissolves directly in the mouth for easier swallowing.
Olanzapine NORMON 10 mg is available in cardboard boxes containing 28 and 56 tablets.
OTHER PRESENTATIONS
Olanzapine NORMON 5 mg orodispersible tablets EFG.
Olanzapine NORMON 15 mg orodispersible tablets EFG.
Olanzapine NORMON 20 mg orodispersible tablets EFG.
Marketing authorization holder and manufacturer
LABORATORIOS NORMON S.A.
Ronda de Valdecarrizo, 6
28760 Tres Cantos
Madrid
SPAIN
This medicine is authorized in the Member States of the European Economic Area under the following names:
Spain Olanzapine NORMON 10 mg orodispersible tablets EFG
This leaflet was approved inApril 2021
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
You can access detailed and updated information about this medicine by scanning the QR code included in the leaflet and packaging with your smartphone.
You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/73600/P_73600.html.
The average price of OLANZAPINE NORMON 10 mg ORALLY DISINTEGRATING TABLETS in October, 2025 is around 52.89 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.